Download these expert-selected slides on current best practices for early stage relapsed/refractory multiple myeloma to help diagnose and manage your patients.
Download these expert-selected slides on current best practices for later-stage relapsed/refractory multiple myeloma and investigational agents in this setting.
Download these expert-selected slides on current and investigational anti-BCMA CAR T-cell and bispecific therapies for relapsed/refractory multiple myeloma.
In this on-demand webcast from a live symposium, Paul G. Richardson, MD; Natalie S. Callander, MD; and Noopur Raje, MD explore the latest advances in new and emerging therapies for patients with relapsed or refractory multiple myeloma.
Multiple myeloma experts answer audience questions from a recent symposium on strategies for incorporating novel therapies for the treatment of relapsed or refractory multiple myeloma into clinical practice and managing toxicities with approved and investigational agents.